loader image
Saturday, January 17, 2026
57.3 F
McAllen
- Advertisement -

New Board-Certified Pediatric Neurologist Joins DHR Health Neurology Institute

DHR Health Neurology Institute Welcomes Sohail Malek, M.D., Pediatric Neurologist for the Rio Grande Valley

Translate to Spanish or other 102 languages!

Sohail Malek, M.D., new Pediatric Neurologist at DHR Health Neurology Institute.

Mega Doctor News

- Advertisement -

Edinburg, TX – DHR Health is proud to announce that Sohail Malek, M.D., will join their exceptional team of neurology specialists at the DHR Health Neurology Institute.

Dr. Malek is board certified in Neurology with a special qualification in Pediatric Neurology since 2014. He brings life-saving experience with recognizing and treating the diseases affecting the brains and nerves of our youngest population. He will also be establishing a multi-disciplinary sports concussion clinic utilizing cutting edge research and technology.

He received his Doctor of Medicine from Albany Medical College and has served at that institution as Assistant Professor of Pediatric Neurology and Director of Pediatric Neuromuscular Care. He is a graduate of Cornell University and trained as a Pediatric Resident and Child Neurology Fellow at Tufts Medical Center in Boston, MA.

- Advertisement -

Dr. Malek has performed community service in New England, upstate New York and Haiti as a representative of the Islamic Medical association of North America, and hopes to continue helping the most vulnerable children in the Rio Grande Valley.

“The mind of a developing child is a precious thing for any family. I have dedicated my life to research ways to help his patients and the community reach their full potential,” said Malek.

For more information on the services provided at DHR Health Neurology Institute or to schedule an appointment with Dr. Sohail Malek, please call (956) 362-8300 or visit our website at www.dhrhealth.com.

About DHR Health Neurology Institute…

- Advertisement -

The DHR Health Neurology Institute is dedicated to providing excellence in neurologic care to all of our patients, both adult and pediatric. Our multidisciplinary team is nationally recognized for providing expert care for evaluating and treating even the most complex and challenging brain and nervous system disorders – with and without surgery. As the first Joint Commission Certified Comprehensive Stroke Center in the region and Level I Comprehensive Stroke Center, we are the leading neuroscience group in the Rio Grande Valley and the premiere center for minimally invasive neurosurgery and neuroendoscopy.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Backs Education at 30th Annual VAMOS Golf Tournament

The Valley Alliance of Mentors for Opportunities and Scholarships (VAMOS) will hold a press conference on Wednesday, January 28, 2026, at 10:00 a.m. at the Edinburg Conference Center at Renaissance, located at 118 Paseo Del Prado, Edinburg, TX 78539,  to announce DHR Health as the Presenting Sponsor of the 30th Annual VAMOS Golf Tournament, scheduled for Saturday, March 7, 2026 at Champion Lakes Golf Course in McAllen, Texas. This is the organization’s largest fundraiser and one of the most anticipated charitable sporting events in the region.

Abbott Directs State Agencies to Probe Possible Medicaid Fraud

Governor Greg Abbott sent a letter directing the Texas Health and Human Services (HHS) Office of Inspector General and the Texas Health and Human Services Commission (HHSC) to launch investigations into potential Medicaid fraud in Texas to safeguard taxpayer funds, maintain access for eligible Texans, and ensure efficient, high-quality healthcare delivery.

STHS McAllen Opens $12 Million Neuro ICU

Frequently complex in nature, brain and spinal cord injuries and illnesses require specialized care for a patient’s successful recovery.

Scientists Identify a Treatable Vulnerability in Aggressive Blood Cancer

New research co-led by Indiana University School of Medicine scientists has exposed a vulnerability in acute myeloid leukemia by identifying the blood cancer's reliance on a specific signaling pathway involved in the body's inflammation response.
- Advertisement -
×